Adding digital breast tomosynthesis to digital mammography significantly increases the accuracy of the mammography, compared with full-field digital mammo.
Adding the use of digital breast tomosynthesis to digital mammography increases the accuracy of the mammography, compared with full-field digital mammography, according to a study in the October issue of Clinical Radiology.
Researchers from King’s College Hospital in London, UK, evaluated 738 women who between January 2009 and July 2010 had been recalled for assessment following routine screening with screen-film mammography. All women underwent bilateral two-view full-field digital mammography (FFDM) and two-view digital breast tomosynthesis (DBT). Lesions on the images were scored separately for probability of malignance on the screen-film mammography, FFDM and DBT.
The readers found 204 malignancies (26.8 percent), of which 147 were invasive and 57 were in situ tumors. Two hundred eight six (37.68 percent) were benign and 269 (35.4 percent) were considered normal.
Using receiver operator characteristics (ROC) analysis and measurement of area under the curve (AUC), the researchers assessed and compared the accuracy of the three imaging methods.
According to the AUC values, diagnostic accuracy significantly improved when DBT was combined with either FFDM or film-screen mammography (AUC = 0.9671), when compared to FFDM plus film-screen mammography (AUC = 0.8949) and film-screen mammography alone (AUC = 0.7882). Soft-tissue lesions were detected significantly more often with the combination imaging as well.
“The addition of DBT increases the accuracy of mammography compared to FFDM and film-screen mammography combined and film-screen mammography alone in the assessment of screen-detected soft-tissue mammographic abnormalities,” the authors concluded.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.